Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hisamitsu Pharmaceutical Co., Inc.
Randomized, double-blind, placebo-controlled, multicenter study in men and women 18 years of age or greater who have acute shoulder pain requiring analgesic treatment daily for at least 2 weeks.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The subject has unilateral acute shoulder pain.
You may not be if
The subject is a women of childbearing potential who has a positive urine pregnancy test, or who is lactating, or who is not surgically sterile (by tubal ligation or hysterectomy), or at least 2 years postmenopausal, and has not practiced an acceptable form of birth control (defined as the use of an intrauterine device with spermicide, a barrier method with spermicide, condoms with spermicide, subdermal implant, oral contraceptives, or abstinence) for at least 2 months prior to Visit 1.
